102 related articles for article (PubMed ID: 2867017)
1. [Cerebrovascular circulation and metabolism. Action of calcium overload blockers].
Fortschr Med Suppl; 1985; 8():10-1. PubMed ID: 2867017
[No Abstract] [Full Text] [Related]
2. [Brain protection must be simultaneously specific and complex. Versatile effect of certain calcium antagonists].
Fortschr Med Suppl; 1985; 8():18-9. PubMed ID: 2867022
[No Abstract] [Full Text] [Related]
3. [Calcium antagonists and cerebrovascular circulation].
De Gregorio C
Clin Ter; 1987 Oct; 123(1):41-50. PubMed ID: 2972466
[No Abstract] [Full Text] [Related]
4. [Cerebral protective effects by continuous administration of a calcium antagonist after canine global brain ischemia--change in cerebral blood flow and metabolism].
Ono K; Iwatsuki N; Obara S; Hashimoto Y
Masui; 1988 Jan; 37(1):23-8. PubMed ID: 3367498
[No Abstract] [Full Text] [Related]
5. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
Kyoi K; Utsumi S
Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
[No Abstract] [Full Text] [Related]
6. [Cerebral circulation and calcium antagonists].
Uematsu D; Fukuuchi Y
No To Shinkei; 1990 Jan; 42(1):17-31. PubMed ID: 2186763
[No Abstract] [Full Text] [Related]
7. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
[TBL] [Abstract][Full Text] [Related]
8. [Therapy in the early stage of cerebral insufficiency. Clinical and technical possibilities for evaluating the vascular system].
Fortschr Med Suppl; 1986; 1():9-10. PubMed ID: 2868982
[No Abstract] [Full Text] [Related]
9. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.
Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M
J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563
[TBL] [Abstract][Full Text] [Related]
10. Brain ischemia as a target for Ca2+ entry blockers.
Wauquier A; Ashton D; Clincke GH
Ann N Y Acad Sci; 1988; 522():478-90. PubMed ID: 3288057
[No Abstract] [Full Text] [Related]
11. Clinical benefit of slow calcium channel antagonists in cerebral ischaemia.
Lapalus P; Drici MD; Iacono P
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():134A. PubMed ID: 1498781
[No Abstract] [Full Text] [Related]
12. [Calcium channel blockers and cerebral circulation].
Uematsu D; Fukuuchi Y
Nihon Rinsho; 1989 Aug; 47(8):1770-5. PubMed ID: 2585739
[No Abstract] [Full Text] [Related]
13. [Physiopathologic bases and prospects in the prevention and medical therapy of vascular brain diseases with an ischemic base].
Peruzzi G; Raimondi G; Baldoni F; Grimaldi I; Di Nardo P; Bellegrandi F; Tallarida G
Clin Ter; 1987 Feb; 120(4):275-98. PubMed ID: 2953529
[No Abstract] [Full Text] [Related]
14. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
Sood AK; Dua A; Mahajan A; Arora S
J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106
[No Abstract] [Full Text] [Related]
15. [Cerebral pharmacologic protection].
Baldy-Moulinier M
Agressologie; 1982; 23(C):3-8. PubMed ID: 7125088
[No Abstract] [Full Text] [Related]
16. Calcium channel blockers in myocardial and cerebral ischemia: a clinician's review from bench to bedside.
Borger MA; Weisel RD
Can J Cardiol; 1999 Mar; 15(3):333-40. PubMed ID: 10202197
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
[TBL] [Abstract][Full Text] [Related]
18. [The influence of cinnarizine and alvityl on cerebral blood flow and high nervous activity in chronic cerebral ischemia model].
Gromova OA; Grishina TR; Sadin AV; Nikonov AA; Nazarenko OA; Zhidomorov NIu; Vatsuro AA; Borzunov MP
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):52-3. PubMed ID: 14870694
[No Abstract] [Full Text] [Related]
19. [Calcium antagonists in the therapy of cerebrovascular diseases].
Cosmi F
Clin Ter; 1985 Mar; 112(5):465-8. PubMed ID: 4017471
[No Abstract] [Full Text] [Related]
20. Relationship between regional calcium content and energy metabolism during recovery from prolonged cerebral ischemia.
Grosse Ophoff B; Hossmann KA; Bodsch W; Paschen W
Monogr Neural Sci; 1984; 11():22-7. PubMed ID: 6738553
[No Abstract] [Full Text] [Related]
[Next] [New Search]